mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma. - Wikidata - wikimedia - TriplyDB

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q33203570

about

Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3.Photodynamic therapy outcome for oral dysplasia.Photodynamic therapy: The minimally invasive surgical intervention for advanced and/or recurrent tongue base carcinoma.Photodynamic therapy outcome for T1/T2 N0 oral squamous cell carcinoma.Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window-chamber tumor model.Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx.Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients RUNX3 confers sensitivity to pheophorbide a-photodynamic therapy in human oral squamous cell carcinoma cell lines.Photodynamic therapy for photochemists.Efficacy of krypton laser photodynamic therapy for oral mucosa dysplasia in 9,10-dimethyl-1,2-benzanthracene-treated hamsters.Photodynamic therapy of cancer: an update Combinatorial screening for specific drug solubilizers with switchable release profiles.O2 and Ca(2+) fluxes as indicators of apoptosis induced by rose bengal-mediated photodynamic therapy in human oral squamous carcinoma cells.Prostate PDT dosimetry.Angiopoietin-1-expressing adipose stem cells genetically modified with baculovirus nanocomplex: investigation in rat heart with acute infarction.A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.Biomodulatory approaches to photodynamic therapy for solid tumors Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review.The future of photodynamic therapy in oncology.A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer Photodynamic therapy treatment of early oral and laryngeal cancers.Monitoring photodynamic therapy of head and neck malignancies with optical spectroscopies.Histopathological change of oral malignant tumour and epithelial dysplasia subjected to photodynamic therapy.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Photodynamic therapy in the management of potentially malignant and malignant oral disorders.Liposomes in topical photodynamic therapy.Photodynamic therapy: oncologic horizons.Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells.Photodynamic therapy in the upper aerodigestive tract. Overview and outlook.Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC-3 cells.Development and characterization of bio-derived polyhydroxyalkanoate nanoparticles as a delivery system for hydrophobic photodynamic therapy agents.Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.Synthesized Pheophorbide a-mediated photodynamic therapy induced apoptosis and autophagy in human oral squamous carcinoma cells.mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment.Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral squamous cell carcinoma.Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation 3B, a novel of photosensitizer, exhibited anti-tumor effects via mitochondrial apoptosis pathway in MCF-7 human breast carcinoma cells.Polymer platforms for drug delivery and biomedical imaging New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.Lesion Oxygenation Associates with Clinical Outcomes in Premalignant and Early Stage Head and Neck Tumors Treated on a Phase 1 Trial of Photodynamic Therapy.

P2860

Q31084556-488776A2-3E51-4CDA-A7ED-87EB8C51D966 Q33849082-5EA8C93B-A7A5-4C30-AB7F-707EBDD731AD Q33875338-F4DA13B8-4586-4E76-A409-6088113FF6B4 Q33962094-4AB58685-98AD-412A-9467-0A14C7470268 Q33962146-3E0194AA-E448-4340-B622-D8D04FB5F3D4 Q34394997-B1ED0C5F-62E1-447D-8A39-E25485CDAE04 Q34491486-C00988C9-553B-40B0-A6D4-4A352C7D0AE9 Q34734701-13EF5666-0B4C-4889-88E5-20CF1939790C Q34775481-57792AC3-3545-4A1C-AB12-7255D9FE818C Q35030136-64276CEF-CAAD-42FD-B26B-3971427E1CFD Q35532394-DE4FD899-8545-449A-B78B-1B6ADAB7A428 Q35537690-914A9B29-F6A5-4B51-833A-EF31E41B62B7 Q35625066-FAB6C230-23DB-4EE7-B50D-39A43BCA141E Q35748396-7F9D8906-F468-4FE2-961E-DB9A010C4CF5 Q35753063-19BCDFBE-7BF1-4D48-B666-9904569491D4 Q35845509-A269982C-8A49-4155-87FE-B5CC16AD2499 Q36283013-70E66B8C-0A18-4607-AE8B-809412689F28 Q36365477-B117497D-3CBA-4BC6-A65B-0CFDF1E34622 Q36429669-0BF45B74-C202-4FBF-A7EB-33DCA62C0C64 Q36632064-BA02FA45-C5C7-4FAC-8977-4F2C1470A4BC Q36945981-CA9F8DEB-E742-44B6-A61F-A04CCA499CD9 Q37354626-A0F4983B-DDED-402A-A066-6BA5962286EE Q37454632-4A86D707-DE7F-45D4-B8A7-0A2FBCBB51AC Q37919156-0987FE11-1422-4767-86CC-EF4342E89FEC Q38006577-6FB7A488-E16F-473C-B2FB-8E1B5661F9F0 Q38021510-50E4CE7D-152C-4415-845D-05425FE92FDC Q38170385-E4166FD5-B97E-4EF1-969B-17BCBFCCA55C Q38448690-957B269C-1184-4AC8-83FA-BBEB482ADEDE Q38787155-6D1DB377-204D-4E3E-AEA2-24BE110A7E3E Q38790798-396472FE-685B-484F-A458-684D48D4EC23 Q38808333-578112D1-F62F-4689-9624-6C2798EEC266 Q38838562-93572DF6-C114-4058-A91E-F6B2CE03138B Q39323531-14A25DEE-B087-4411-B7A0-4DCF89C71874 Q39416520-B0ECE010-D5F6-4995-9BE1-6CD0D0A39EAB Q39425739-C820606D-91F0-4B02-A6EB-3DAB6554DAC8 Q39965904-416EE6B4-B072-4F27-BBFC-F6418FF71F45 Q41343233-FA1C8056-6305-4CB0-8074-56BAEA2F816E Q41873416-6345CFFE-802C-4BDC-83B7-FA8B3151F5CB Q47246957-215ABA96-EDFB-4D85-A5BF-C1F203EAA860 Q50117212-63D4EFB2-194D-4610-9EFF-567D2D06DFF6

P2860

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

http://www.wikidata.org/entity/Q33203570

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@ast

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@en

type

label

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@ast

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@en

prefLabel

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@ast

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@en

P1433

Q33203570-DB85710F-5000-48FF-B3DC-219E149EC0A6

P1476

Q33203570-28E101C3-77C6-42C5-AB7F-2DB7AF01C69E

P2093

Q33203570-0E5247FC-06B3-4ED4-BE0F-9A7691C95BD5

Q33203570-22A7F72D-2311-47EA-90E5-65ACA868750B

Q33203570-2614CBC2-7460-446D-BABD-359532515E56

Q33203570-6EB69D44-EE8A-4F65-8803-68DBA55B4B5F

Q33203570-AD83C22B-67E1-4F7C-8BB7-AF3559400650

P2860

Q33203570-4E6D9936-B068-4201-9834-EFD7644E49A8

Q33203570-50C756A2-4F16-41E2-A902-5663C0F9FB54

Q33203570-5D4E1D22-2588-4EC5-AACD-7C032C03C981

Q33203570-634A4F64-4A91-4E1A-ABCA-824026CD5A34

Q33203570-8B47F09B-9D43-4FE6-B38D-7CB88C8F8C31

Q33203570-C80802AD-E745-4D22-8A20-BA7A9A1663EA

Q33203570-CFFCA2CA-EC98-4536-BCD7-BF6772C221BF

Q33203570-F49EF894-5541-4D5D-A986-B075DC028BA6

P304

Q33203570-6B87455C-E951-494B-91AC-291E48639D65

P31

Q33203570-2AF50A7F-8A66-45B1-B3E1-8B20495A8216

P356

Q33203570-0A3A7371-8783-4E11-BE1B-4AAC3C082B53

P433

Q33203570-2D2B4DE4-19A7-4705-BAD8-FC0FD7DD9DD7

P478

Q33203570-77C4E942-3BF7-4B9B-AAF3-713F9D32AA60

P577

Q33203570-BAB6B699-5C04-4F75-A3C9-84FE299197D7

P5875

Q33203570-F71CE195-777B-4A40-8573-F91DEFCECD66

P698

Q33203570-01388911-9E11-455E-BF96-C1F59BF58E3B

P356

P1433

International Journal of Cancer

P1476

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

@en

P2093

Alexander Kübler

http://www.w3.org/2001/XMLSchema#string

Colin Hopper

http://www.w3.org/2001/XMLSchema#string

Graham Putnam

http://www.w3.org/2001/XMLSchema#string

Harry Lewis

http://www.w3.org/2001/XMLSchema#string

I Bing Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Photodynamic therapy: a clinical reality in the treatment of cancer.

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

Burns after photodynamic therapy.

Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma.

Elective neck dissection versus observation in the treatment of early oral tongue carcinoma.

Estimates of the worldwide incidence of 25 major cancers in 1990.

Photodynamic therapy and the treatment of head and neck neoplasia.

A return to "normal eating" after curative treatment for oral cancer. What are the long-term prospects?

P304

138-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.20209

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8522438

http://www.w3.org/2001/XMLSchema#string

P698

15185355

http://www.w3.org/2001/XMLSchema#string